Pharmalicensing.com: PR Newswire: Financial Agreements http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: PR Newswire: Financial Agreements http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic VANCOUVER, November 5 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3936 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3936 Thu, 05 Nov 2009 12:58:00 +0000 Largest British Fund for Biomedical Research Finances Project on Breakbone Fever in Leuven (K.U.Leuven) LEUVEN, Belgium, October 26 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3864 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3864 Mon, 26 Oct 2009 09:00:00 +0000 Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process WELLESLEY HILLS, Massachusetts, October 22 /PRNewswire/ -- The previously announced auction of assets of EPIX Pharmaceuticals, Inc. was conducted on October 21, 2009. As of today, claims filed... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3854 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3854 Thu, 22 Oct 2009 20:39:00 +0000 Biocartis Raises EUR10 Million in Series A Financing Round LAUSANNE, Switzerland, October 15 /PRNewswire/ -- Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3813 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3813 Thu, 15 Oct 2009 09:09:00 +0000 Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners CAMBRIDGE, England, October 12 /PRNewswire/ -- Crescendo Biologics ("Crescendo") today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its fragment... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3790 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3790 Mon, 12 Oct 2009 09:48:00 +0000 BMEYE B.V. Completes EUR 6 Million Series B Financing Round AMSTERDAM, October 8 /PRNewswire/ -- BMEYE B.V., the non-invasive cardiovascular monitoring company, today announced the successful completion of its Series B financing round, raising EUR 6 million.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3780 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3780 Thu, 08 Oct 2009 08:00:00 +0000 Assist America Sponsors the Bedouin Heritage Project PRINCETON, New Jersey, October 7 /PRNewswire/ -- Assist America, Princeton, N.J., U.S.A., is pleased to announce its sponsorship of the Bedouin Heritage Project, an organization dedicated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3777 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3777 Wed, 07 Oct 2009 18:50:00 +0000 Accumetrics Announces US$16.5M in New Capital Financing SAN DIEGO, October 6 /PRNewswire/ -- Accumetrics, Inc., developer and marketer of the VerifyNow(R) System, the first rapid and easy-to-use diagnostic system for measuring an individual's response to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3769 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3769 Tue, 06 Oct 2009 13:30:00 +0000 Bicycle Therapeutics Ltd, a New Medical Research Council (MRC) Spin-out, Seeking to Merge Best Aspects of Small Molecules and Biologics, Secures Seed Funding From Top Venture Capital Firms LONDON, October 6 /PRNewswire/ -- Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics, has secured... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3764 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3764 Tue, 06 Oct 2009 09:00:00 +0000 Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and Development DUBAI, UAE, October 6 /PRNewswire/ -- Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, has ventured into biotechnology and nanotechnology-based research and manufacturing capabilities. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3761 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3761 Tue, 06 Oct 2009 06:30:00 +0000 Elsevier Launches SciVal Funding Solution to Help U.S. Research Institutions Better Compete for Grants AMSTERDAM, September 28 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVal Funding, a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3723 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3723 Mon, 28 Sep 2009 06:09:00 +0000 Agendia Raises US $23 Million in Series E Financing HUNTINGTON BEACH, California and AMSTERDAM, September 22 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the successful closing of a US $23 million series E... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3691 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3691 Tue, 22 Sep 2009 16:55:00 +0000 ProFibrix Raises US $11 Million (EUR 8 Million) in Series B Financing LEIDEN, The Netherlands and SEATTLE, August 24 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3497 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3497 Mon, 24 Aug 2009 07:00:00 +0000 AdvanDx Closes US$8 Million Financing Round and Elects New Board Member WOBURN, Massachusetts and VEDBAEK, Denmark, August 18 /PRNewswire/ -- AdvanDx today announced it has closed another US$8 million in financing from existing stockholders, SLS Venture and LD Pensions.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3479 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3479 Tue, 18 Aug 2009 07:00:00 +0000 Altacor Beats Biotech Funding Drought CAMBRIDGE, England, August 13 /PRNewswire/ -- Ophthalmology development and marketing company Altacor has announced closing of a GBP1m first tranche of Series B funding. The round was led by two new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3467 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3467 Thu, 13 Aug 2009 09:00:00 +0000 CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research EINDHOVEN, The Netherlands, August 4 /PRNewswire/ -- With today's final approval of a research project into prostate cancer, the Dutch CTMM (Center for Translational Molecular Medicine) today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3435 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3435 Tue, 04 Aug 2009 10:33:00 +0000 Long-term Investment Secured - Swiss Foundation Supports Innovative Concept for Patients With Diabetes Z http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3326 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3326 Fri, 03 Jul 2009 09:00:00 +0000 Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals UPPSALA, Sweden, June 29 /PRNewswire/ -- Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3296 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3296 Mon, 29 Jun 2009 10:19:00 +0000 Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates OSLO, Norway, June 26 /PRNewswire/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3288 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3288 Fri, 26 Jun 2009 10:44:00 +0000 Cappella Inc. Secures US$17.3 Million Series C Investment WILMINGTON, Delaware and GALWAY, Ireland, June 15 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3211 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3211 Mon, 15 Jun 2009 07:00:00 +0000 Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing DUBLIN, May 19 /PRNewswire/ -- Opsona Therapeutics, a biotechnology company focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases, today announced that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3072 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3072 Tue, 19 May 2009 07:00:00 +0000 PhotoThera Closes US$50 Million Financing, Announces New President and Chief Executive Officer CARLSBAD, California, April 30 /PRNewswire/ -- PhotoThera, Inc., the developer of transcranial laser therapy (TLT) designed for the treatment of acute ischemic stroke within 24 hours of stroke onset,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2980 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2980 Thu, 30 Apr 2009 17:00:00 +0000 Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM OXFORD, England, April 24 /PRNewswire/ -- PharmaVentures Ltd, announced today that it has been engaged by Merck & Co, Inc. to advise and assist in divesting its world class research centre, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2943 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2943 Fri, 24 Apr 2009 09:50:00 +0000 ViewRay Incorporated Closes US$15M Tranche of Series B Financing and Announces Partnership with Siemens AG OAKWOOD VILLAGE, Ohio, April 14 /PRNewswire/ -- ViewRay Incorporated, a medical device company, announces the close of the second tranche of their US$25M Series B financing. Funding was triggered by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2878 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2878 Tue, 14 Apr 2009 06:42:00 +0000 Cell Biosciences Closes US$10 Million Series C Financing PALO ALTO, California, April 9 /PRNewswire/ -- Cell Biosciences, a provider of nanoproteomic analysis systems to life science researchers, today announced the closing of a US$10 million Series... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2871 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2871 Thu, 09 Apr 2009 14:00:00 +0000 Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - the Dutch public-private partnership committed to the research and development of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2692 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2692 Tue, 10 Mar 2009 16:22:00 +0000 Victory Pharma Announces US$45 Million Equity Financing SAN DIEGO, March 9 /PRNewswire/ -- Victory Pharma, Inc. ("Victory" or "the Company"), a privately held specialty pharmaceutical company, today announced that it has closed on a US$45 million equity... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2679 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2679 Mon, 09 Mar 2009 07:17:00 +0000 Eiger BioPharmaceuticals Raises US$7.1 Million 'A' Round PALO ALTO, California, February 26 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised US$7.1 million in a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2629 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2629 Thu, 26 Feb 2009 15:51:00 +0000 Summer Street Research Partners Closes Two More Healthcare Company Financings BOSTON, January 27 /PRNewswire/ -- Summer Street Research Partners, a healthcare-dedicated investment firm, is pleased to announce that it served as exclusive U.S. Placement Agent in the 6.4 mln... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2481 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2481 Tue, 27 Jan 2009 16:46:00 +0000 ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF) LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire/ -- ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV) announce today that they have received a technology... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2465 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2465 Mon, 26 Jan 2009 07:00:00 +0000 Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding MONT-SAINT-GUIBERT, Belgium, January 19 /PRNewswire/ -- Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2432 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2432 Mon, 19 Jan 2009 10:13:00 +0000 MS Society Statement: Personal Budgets in Healthcare LONDON, January 16 /PRNewswire/ -- Following today's formal announcement by the Department of Health of the Health Bill and specifically the extension of personal budgets to healthcare for people... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2427 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2427 Fri, 16 Jan 2009 10:29:00 +0000 Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline CAMBRIDGE, England, January 12 /PRNewswire/ -- Biotica Technology Limited, a privately-held biotechnology company, announces a significant Collaboration and License Agreement with GlaxoSmithKline to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382 Mon, 12 Jan 2009 07:00:00 +0000 DNA Jewel to Finance Anti-Aging Services & Cancer Research GENEVA, Switzerland, December 15 /PRNewswire/ -- Swiss-based http://www.dnartistic.com's first piece of DNA luxury jewellery will be sold at 1 million CHF and some of the proceeds will be used to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2305 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2305 Mon, 15 Dec 2008 14:29:00 +0000 Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing LAUSANNE, Switzerland, December 10 /PRNewswire/ -- Diagnoplex, a developer of molecular cancer diagnostics today announced the closing of a Series A financing raising CHF10 million ($8.3 million).... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2282 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2282 Wed, 10 Dec 2008 06:56:00 +0000 AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing PHILADELPHIA, October 31 /PRNewswire/ -- AVAX Technologies, Inc. (OTC Bulletin Board: AVXT) (the "Company") today announced that on October 24, 2008, it closed a bridge loan financing pursuant to a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2029 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2029 Fri, 31 Oct 2008 19:05:00 +0000 Avantium Completes EUR 18 Million Financing Round AMSTERDAM, October 29 /PRNewswire/ -- Avantium announced today the successful completion of a EUR 18 million private financing round. Avantium is active in the development and commercialization of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2015 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2015 Wed, 29 Oct 2008 15:00:00 +0000 Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World HALIFAX, Canada, October 20 /PRNewswire/ -- Ocean Nutrition Canada Limited (ONC), supplier of MEG-3(R) brand Omega-3 EPA/DHA from fish oil to the food and dietary supplement industries is pleased to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1940 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1940 Mon, 20 Oct 2008 21:56:00 +0000 Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth CLEVELAND, Ohio and TEL AVIV, Israel, October 15 /PRNewswire/ -- Simbionix USA Corporation is pleased to announce the completion of a Series C round of growth capital financing led by River Cities... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1919 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1919 Wed, 15 Oct 2008 12:58:00 +0000 Michael J. Fox Foundation Awards $2 Million Grant from Merck Serono to Research Projects on Cognitive Deficits in Parkinson's Disease GENEVA, Switzerland, October 14 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded a total of $2 million to five research teams to speed development of effective... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1911 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1911 Tue, 14 Oct 2008 09:00:00 +0000 DxTech Receives Development Funding MERRIMACK, New Hampshire, October 1 /PRNewswire/ -- DxTech LLC ("DxTech"), an innovative company focused on defining a new direction in global diagnostics by putting high-quality... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1841 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1841 Wed, 01 Oct 2008 19:37:00 +0000 Trillium Secures Additional Financing on the Strength of Lead Program and Proprietary Position Around the CD200 Immunoregulatory Pathway TORONTO, Canada, September 18 /PRNewswire/ -- Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1755 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1755 Thu, 18 Sep 2008 12:00:00 +0000 Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government PORTON DOWN, England, September 18 /PRNewswire/ -- Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics Company, announces that it has been awarded a grant of GBP1.8M from... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1751 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1751 Thu, 18 Sep 2008 09:00:00 +0000 BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company's Dermatology Product TURKU, Finland, September 9 /PRNewswire/ -- BioCis Pharma Ltd announced that it has received almost 1.6 million EURO new R&D financing. The money is specifically targeted for the clinical testing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1681 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1681 Tue, 09 Sep 2008 08:00:00 +0000 Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores NEW DELHI, August 21 /PRNewswire/ -- Omaxe Infrastructure & Construction Private Ltd(OICPL), a wholly owned subsidiary of Omaxe Ltd has received a Letter of Intent for the construction of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1554 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1554 Thu, 21 Aug 2008 15:50:00 +0000 MDL Receives GBP600k in New Funding Round for World-Beating Cancer Diagnosis and Treatment Device LONDON, August 4 /PRNewswire/ -- Successful results and growing sales of Michelson Diagnostics Ltd's (MDL) Optical Coherence Technology (OCT) systems have encouraged investors to place a further... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1480 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1480 Mon, 04 Aug 2008 14:02:00 +0000 French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia PARIS, July 31 /PRNewswire/ -- The French agency Agence de Médecine Préventive (AMP) has received a grant of 10 million dollars from the Bill & Melinda Gates Foundation to support the development... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1469 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1469 Thu, 31 Jul 2008 08:00:00 +0000 Patheon Reaches Agreement With BSP Pharmaceuticals for Development and Manufacture of Cytotoxics TORONTO, July 2 /PRNewswire/ -- Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, has completed a shareholders... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1336 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1336 Wed, 02 Jul 2008 22:00:00 +0000 Elsevier Foundation Seeks Grant Proposals for Innovative Libraries and New Scholars NEW YORK, June 24 /PRNewswire/ -- The Elsevier Foundation is seeking grant proposals for its Innovative Libraries in Developing Countries and New Scholars programs. Grant proposals for the two... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1279 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1279 Tue, 24 Jun 2008 17:30:00 +0000 Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics (ASX: BNO) was signed, under... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 Wed, 18 Jun 2008 13:00:00 +0000 Angioslide Closes US$8.6million Series C Financing HERZLIYA, Israel, June 2 /PRNewswire/ -- Angioslide, Ltd. today announced the closing of an US$8.6 million Series C financing round. Angioslide is the developer of the unique Angioslide eXtra(TM)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1126 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1126 Mon, 02 Jun 2008 12:00:00 +0000 Strong VC-trio Invest in PharmaSurgics Wound Healing Product GOTHENBURG, Sweden, May 28 /PRNewswire/ -- PharmaSurgics AB has received SEK 17 million to complete the preclinical development of their candidate drug (PXL01). The primary indication for PXL01 is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1078 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1078 Wed, 28 May 2008 12:00:00 +0000 Emerging Capital Partners Invests U.S. $47.3 Million in North African Personal Care Company WASHINGTON, May 21 /PRNewswire/ -- Emerging Capital Partners (ECP), an international private equity firm focused on investing across the African continent, today announced a U.S. $47.3 million... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1050 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1050 Wed, 21 May 2008 12:00:00 +0000 Albireo Announces Second Closing of Series A Financing GOTHENBURG, Sweden, May 7 /PRNewswire/ -- Albireo, a recent spinout from AstraZeneca focused on gastrointestinal diseases, today announced a second closing of its Series A financing. The capital... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/933 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/933 Wed, 07 May 2008 08:00:00 +0000 Non-Invasive Glucose Monitoring - Solianis Monitoring AG: Supported by the Zürich Cantonal Bank and the European Union ZURICH, Switzerland, May 5 /PRNewswire/ -- The research for non-invasive glucose monitoring has found new investors: The Zürich Cantonal Bank will invest in Solianis; together with a research grant... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/916 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/916 Mon, 05 May 2008 10:13:00 +0000 Submissions for the 2008 EFIC-Grunenthal Grant AACHEN, Germany, April 21 /PRNewswire/ -- Submissions for the 2008 EFIC-Grunenthal Grant will be accepted by 31st May 2008. This annual grant of EUR 100,000 is awarded in co-operation with the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/825 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/825 Mon, 21 Apr 2008 14:35:00 +0000 Potentia Pharmaceuticals Secures Additional US$12 Million in Funding LOUISVILLE, Kentucky, April 9 /PRNewswire/ -- Potentia Pharmaceuticals, Inc., a private development-stage biotechnology company, announced today that it has completed a US$12 million round... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/756 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/756 Wed, 09 Apr 2008 13:00:00 +0000 D-Pharm Secures Funding From Israel's Chief Scientist's Office REHOVOT, Israel, April 7 /PRNewswire/ -- D-Pharm announced today that it received notice from Israel's Chief Scientist's Office (CSO) of its commitment to match expenditures on four of D-Pharm's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/733 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/733 Mon, 07 Apr 2008 05:30:00 +0000 Moleac Announces Series A Investment SINGAPORE, April 3 /PRNewswire/ -- Singapore-based Moleac announced that it has raised US$3.5 million. This Series A investment comes from a group of private investors, who are based in both Europe... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/724 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/724 Thu, 03 Apr 2008 07:33:00 +0000 Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease EINDHOVEN, the Netherlands, April 1 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - a Dutch public-private partnership committed to the research and development of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/656 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/656 Tue, 01 Apr 2008 12:12:00 +0000 Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round FREISING-WEIHENSTEPHAN, Germany, March 27 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, announced today the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/626 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/626 Thu, 27 Mar 2008 10:00:00 +0000 Hikma - 2007 Preliminary Results Interviews With CEO and CFO LONDON, March 18 /PRNewswire/ -- In video interviews Said Darwazah, CEO, and Bassam Kanaan, CFO, discuss Hikma's 2007 performance, financing and acquisitions, plus what they are expecting from the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/586 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/586 Tue, 18 Mar 2008 07:33:00 +0000